Mycobacterium tuberculosis

Mycobacterium tuberculosis research compounds act on enzymes and proteins that the tuberculosis bacterium depends on. The genome of the laboratory strain H37Rv, sequenced in 1998, encodes an unusually large set of enzymes for lipid metabolism. Several entries inhibit decaprenylphosphoryl-β-D-ribose 2′-epimerase (DprE1), an enzyme required for arabinan synthesis in the cell wall. Benzothiazinones, represented here by BTZ043 (BTZ038, BTZ044) Racemate, were shown in 2009 to kill the bacterium by blocking this step. AZ7371 and DprE1-IN-8 are listed as further inhibitors of the same enzyme. PXYC1 and PXYC2 are antagonists of ribosomal protein S1 (RpsA), and MtTMPK-IN-8 inhibits mycobacterial thymidylate kinase. Cefsulodin sodium hydrate is listed as an inhibitor of mycobacterial protein tyrosine phosphatase B (mPTPB), a secreted virulence factor.

Items 51-60 of 60

  • Mtb-IN-2
    Cat. No.
    A49715

    Mtb-IN-2

    Mtb-IN-2 is an antimicrobial agent specifically targeting Mycobacterium tuberculosis (Mtb). Demonstrating significant efficacy, Mtb-IN-2 effectively reduces colony-forming units (CFU) in murine tuberculosis models, providing utility against both drug-sensitive and drug-resistant Mtb H37Rv strains. The compound influences methionine metabolism, while not directly impacting the folate pathway, making it a valuable tool for research into Mtb infection and drug resistance mechanisms.

    1 mg
    $55.00
    5 mg
    $130.00
    All 7 sizes
  • MtTMPK-IN-6
    Cat. No.
    A49760

    MtTMPK-IN-6

    MtTMPK-IN-6 is a selective inhibitor of Mycobacterium tuberculosis thymidylate kinase (MtbTMPK), exhibiting an IC50 value of 29 μM. This compound serves as a valuable tool for investigating the biochemical pathways involved in tuberculosis and may aid in the development of novel therapeutic strategies against M. tuberculosis. Its potency and specificity make it a relevant candidate for further research in the field of infectious diseases.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • MSU-43557
    Cat. No.
    A49822

    MSU-43557

    MSU-43557 is a selective inhibitor of the mycobacterial transporter MmpL3 (MAB_4508), demonstrating potent bactericidal activity against Mycobacterium abscessus. By inhibiting MmpL3, MSU-43557 disrupts the synthesis of trehalose monomycolate, leading to a significant reduction in the viability of biofilm-associated M. abscessus and intracellular forms. This compound exhibits low cytotoxicity in eukaryotic cells and a minimal resistance frequency in M. abscessus strains, making it a valuable tool for research into mycobacterial infections.

    Out of stock

    All 3 sizes
  • Polyketide synthase 13-IN-1
    Cat. No.
    A49837

    Polyketide synthase 13-IN-1

    Polyketide Synthase 13-IN-1 is an inhibitor of polyketide synthase 13, targeting the biosynthetic pathway of polyketides. This compound is significant in research focused on antibiotic development and the synthesis of complex natural products. Its activity provides valuable insights into polyketide metabolism and the potential therapeutic applications of polyketide derivatives.

    5 mg
    $795.00
    All 1 sizes
  • LeuRS-IN-1 hydrochloride
    Cat. No.
    A49844

    LeuRS-IN-1 hydrochloride

    LeuRS-IN-1 hydrochloride is an effective inhibitor of M. tuberculosis leucyl-tRNA synthetase (M.tb LeuRS), showcasing sub-micromolar potency with IC50 and Kd values of 0.06 μM and 0.075 μM, respectively. This compound also inhibits human cytoplasmic leucyl-tRNA synthetase with an IC50 of 38.8 μM and affects protein synthesis in HepG2 cells, demonstrating an EC50 of 19.6 μM. LeuRS-IN-1 hydrochloride is valuable for investigating the mechanisms of antibiotic resistance and for exploring new therapeutic strategies against tuberculosis.

    1 mg
    $1,065.00
    5 mg
    $2,205.00
    All 4 sizes
  • DprE1-IN-10
    Cat. No.
    A49848

    DprE1-IN-10

    DprE1-IN-10 is an inhibitor of Decaprenylphosphoryl-β-D-ribose-2′-epimerase (DprE1), an essential enzyme in the biosynthesis of mycobacterial cell wall components. This compound exhibits strong inhibitory activity against DprE1, making it a valuable tool for researchers studying tuberculosis and exploring potential therapeutic strategies. Its application can lead to significant insights into the mechanisms of mycobacterial infections and the development of antitubercular agents.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Mycobacterium Tuberculosis-IN-2
    Cat. No.
    A49856

    Mycobacterium Tuberculosis-IN-2

    Mycobacterium Tuberculosis-IN-2 is a potent inhibitor specifically targeting Mycobacterium tuberculosis. Demonstrating effective antimicrobial activity with a minimum inhibitory concentration (MIC) ranging from 0.07 to 0.16 μM, this compound serves as a valuable reagent for tuberculosis research, facilitating studies on pathogen resistance and therapeutic development.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • IMB-YH-8
    Cat. No.
    A49938

    IMB-YH-8

    IMB-YH-8 is a selective inhibitor of the serine/threonine protein kinase PknB, demonstrating potent antibacterial activity against Mycobacterium tuberculosis with a minimum inhibitory concentration (MIC) of 0.25 µg/mL. This compound is valuable for researchers investigating tuberculosis, providing insights into the mechanisms of bacterial resistance and potential therapeutic strategies. Its targeted action on PknB enhances its relevance in studies aimed at developing new antimicrobial agents.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • MmpL3-IN-5
    Cat. No.
    A50368

    MmpL3-IN-5

    MmpL3-IN-5 is a specific inhibitor of the MmpL3 protein, which plays a critical role in the cell wall biogenesis of Mycobacterium tuberculosis. It demonstrates significant antitubercular activity, exhibiting a pMIC of 7.0 μM against the H37Rv strain of Mycobacterium tuberculosis. This compound is valuable for research focused on the development of new therapeutic strategies for tuberculosis.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Tuberculosis inhibitor 12
    Cat. No.
    A50545

    Tuberculosis inhibitor 12

    Tuberculosis Inhibitor 12 is an oxadiazole derivative designed to inhibit Mycobacterium tuberculosis. At a concentration of 20 µM, it demonstrates significant inhibition rates of 82% and 78% in 7H9-Tw-OADC media. This compound serves as a valuable tool for research applications aimed at studying tuberculosis and discovering novel therapeutic strategies.

    1 mg
    $30.00
    5 mg
    $65.00
    All 5 sizes

Items 51-60 of 60

Added to your cart

View Cart Checkout

    Loading...